16:30 EST Ginkgo Bioworks (DNA) still sees FY25 revenue $167M-$187M, consensus $177.07M
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DNA:
- Ginkgo Bioworks reports Q3 EPS ($1.45), consensus ($1.24)
- Ginkgo Bioworks awarded $22.2M contract through BARDA BioMaP-Consortium
- Private Markets: Polymarket planning U.S. return with sports focus
- Ginkgo Bioworks extends partnership with Bayer
- Ginkgo Bioworks announces collaboration with STRM.BIO, UBC